DXC Technology Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DXC Technology Company on October 12, 2018. The filing discloses the entry into a material definitive agreement involving a new term loan facility for the company's UK operations.
Key Financial Metrics and Debt
- New Debt Facility: A delayed-draw senior unsecured term loan (the "UK Term Loan") of £450.0 million.
- Expansion Option: The Borrower may request an increase in commitments to £550.0 million at the lenders' discretion.
- Interest Rate: LIBOR plus 0.80%.
- Maturity Date: January 15, 2022, or earlier if the Borrower ceases to be a subsidiary of DXC.
- Draw Period: Advances may be requested from the Effective Date (October 12, 2018) through 30 days thereafter.
- Prepayment: Permitted at any time; principal payments cannot be redrawn.
Material Changes and Use of Proceeds
The primary material change is the establishment of the UK Term Loan. Proceeds from this facility are expected to be used to:
- Repay advances under an existing credit agreement dated December 16, 2015.
- Fund general corporate purposes.
The filing does not provide specific revenue, profit, cash flow, or margin figures for the period, as this is a transactional filing rather than a periodic financial report.
Management Commentary, Risks, and Contingencies
The agreement includes customary representations, warranties, covenants, and events of default consistent with DXC's existing Revolving Credit Agreement. In the event of default, lenders have remedies including the acceleration of repayment of outstanding amounts. The filing notes that the description of the loan is a summary and is qualified by the full text of the Credit Agreement filed as Exhibit 10.1.
Key Facts for Investor Verification
- Verify the exact timing of the drawdown of the £450.0 million facility within the 30-day window.
- Confirm the specific impact of this new debt on the company's overall leverage ratios and debt service obligations.
- Review the full text of the Credit Agreement (Exhibit 10.1) for specific financial covenants and restrictions.
- Monitor whether the option to increase the facility to £550.0 million is exercised.